Serotonergic control of the glutamatergic neurons of the subthalamic nucleus

Prog Brain Res. 2021:261:423-462. doi: 10.1016/bs.pbr.2020.11.003. Epub 2021 Jan 15.

Abstract

The subthalamic nucleus (STN) houses a dense cluster of glutamatergic neurons that play a central role in the functional dynamics of the basal ganglia, a group of subcortical structures involved in the control of motor behaviors. Numerous anatomical, electrophysiological, neurochemical and behavioral studies have reported that serotonergic neurons from the midbrain raphe nuclei modulate the activity of STN neurons. Here, we describe this serotonergic innervation and the nature of the regulation exerted by serotonin (5-hydroxytryptamine, 5-HT) on STN neuron activity. This regulation can occur either directly within the STN or at distal sites, including other structures of the basal ganglia or cortex. The effect of 5-HT on STN neuronal activity involves several 5-HT receptor subtypes, including 5-HT1A, 5-HT1B, 5-HT2C and 5-HT4 receptors, which have garnered the highest attention on this topic. The multiple regulatory effects exerted by 5-HT are thought to be modified under pathological conditions, altering the activity of the STN, or due to the benefits and side effects of treatments used for Parkinson's disease, notably the dopamine precursor l-DOPA and high-frequency STN stimulation. Originally understood as a motor center, the STN is also associated with decision making and participates in mood regulation and cognitive performance, two domains of personality that are also regulated by 5-HT. The literature concerning the link between 5-HT and STN is already important, and the functional overlap is evident, but this link is still not entirely understood. The understanding of this link between 5-HT and STN should be increased due to the possible importance of this regulation in the control of fronto-STN loops and inherent motor and non-motor behaviors.

Keywords: Basal ganglia; Electrophysiology; High-frequency stimulation; Motor behavior; Neurochemistry; Obsessional compulsive disorder; Parkinson's disease; l-DOPA.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Basal Ganglia
  • Humans
  • Neurons
  • Parkinson Disease / therapy
  • Serotonin
  • Subthalamic Nucleus*

Substances

  • Serotonin